AUSTRALIAN pharmaceutical
company Phebra has received final
approval for its new manufacturing
plant in Sydney’s inner north-west.
Lane Cove Council has approved
Phebra’s Development Application
with building expected to
commence next month.
Plant equipment on order will
arrive in Australia in late 2011, with
a cornerstone of the facility being a
new multi-purpose sterile
injectables plant.
“The new plant will expand our
current research programs for the
development of medicines which
we can supply for all-important
clinical trials throughout Australia,”
said ceo Dr Mal Eutick.The above article was sent to subscribers in Pharmacy Daily's issue from 27 Jun 11 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 27 Jun 11
MAYNE Pharma Group Limited has filed a patent infringement suit against Sun Pharmaceutical Industries Ltd and Inc., in the United States District Court, according to yesterday’s ASX announcement.
PHARMACY Connect 2024 conference will feature a provocative ‘Great Debate’ during the Harm Minimisation Workshop on Thu 05 Sep at the Hyatt Regency in Sydney.
LTR Pharma Limited has successfully raised $10.5 million through a share placement to sophisticated and new institutional investors, significantly surpassing initial demand.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.